DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

Pacific Biosciences Q4 Sales $27.93M Beat $25.52M Estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly sales of $27.93 million which beat the analyst consensus estimate of $25.52 million by 9.44 percent. This is a 43.04 percent increase over sales of $19.526 million

Benzinga · 02/06/2020 21:27

Pacific Biosciences (NASDAQ:PACB) reported quarterly sales of $27.93 million which beat the analyst consensus estimate of $25.52 million by 9.44 percent. This is a 43.04 percent increase over sales of $19.526 million the same period last year.